大麻使用与术后阿片类药物消耗、疼痛及呼吸系统并发症的关联:回顾性队列分析
该回顾性队列纳入2010至2020年Cleveland Clinic主院区34,521例成人择期手术患者,其中1,683例术前30天内使用大麻。经倾向评分加权调整后,大麻使用与术后24小时阿片类药物消耗增加(几何均数比1.30,95%CI 1.22-1.38;P<.0001)及时间加权平均疼痛评分升高(均数差0.57,95%CI 0.46-0.67;P<.0001)相关,但与SpO2/FiO2比值及肺部并发症复合终点无显著关联。
要点
- 术前30天内使用大麻与术后24小时阿片消耗增加30%相关。
- 大麻使用与术后疼痛评分轻度升高相关,均数差0.57。
- 大麻使用未显著增加低氧或肺部并发症复合终点风险。
核心结论
- 成人择期手术患者术前使用大麻与术后阿片消耗和疼痛评分显著升高相关,但与低氧或肺部并发症复合终点无临床意义关联。
研究设计与样本
- 排除接受区域麻醉或诊断为慢性疼痛的患者,采用倾向评分逆概率治疗加权(IPTW)调整混杂因素。
主要发现
- 大麻使用者术后24小时阿片消耗的调整几何均数比为1.30(95%CI 1.22-1.38;P<.0001)。
- 大麻使用者时间加权平均疼痛评分均数差为0.57(95%CI 0.46-0.67;P<.0001)。
- 大麻使用与时间加权平均SpO2/FiO2比值无关,调整均数差0.5(95%CI -3.1至4.2;P=.76)。
- 大麻使用与肺部并发症复合终点无关,估计比值比0.90(95%CI 0.71-1.13;P=.34)。
临床怎么用
- 术前应询问大麻使用情况,并将其视为术后阿片需求增加和疼痛评分升高的潜在因素。
- 对大麻使用者术后镇痛方案可个体化调整,但无需常规预期低氧或肺部并发症风险升高。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Cannabis is a widely used illicit drug with effects on different pain pathways. However, interactions between cannabis and postoperative pain are unclear. Cannabis smoking also affects the lungs, but the impact of cannabis use on postoperative pulmonary complications is unknown. We hypothesized that preoperative cannabis use in adults having elective surgery is associated with higher postoperative opioid consumption. Secondarily, we tested the hypothesis that cannabis use is associated with higher pain scores, hypoxemia (oxygen saturation [Sp o2 ]/fraction of inspired oxygen [F io2 ] ratio), and higher postoperative pulmonary complications compared to nonuse of cannabis. METHODS: In this retrospective study, we included adult patients who had elective surgeries at Cleveland Clinic Main Campus between January 2010 and December 2020. The exposure was use of cannabis within 30 days before surgery, and the control group never used cannabis. Patients who had regional anesthesia or chronic pain diagnosis were excluded. The primary outcome was postoperative opioid consumption; 3 secondary outcomes were time-weighted average (TWA) postoperative pain score, TWA Sp o2 /F io2 ratio, and composite of pulmonary complications after surgery. We assessed the association between cannabis use and opioid consumption during the first 24 postoperative hours using linear regression on log-transformed opioid consumption with a propensity score-based method (inverse probability of treatment weighting [IPTW]) adjusting for confounders. We further adjusted for imbalanced confounding variables after IPTW was applied. RESULTS: In total, 1683 of 34,521 patients were identified as cannabis users. Cannabis use was associated with increased opioid consumption, with an adjusted ratio of geometric means (95% confidence interval [CI]) of 1.30 (1.22-1.38; P < .0001) for cannabis users versus nonusers. Secondarily, (1) cannabis use was associated with increased TWA pain score, with a difference in means of 0.57 (95% CI, 0.46-0.67; P < .0001); (2) cannabis use was not associated with TWA Sp o2 /F io2 , with an adjusted difference in means of 0.5 (95% CI, -3.1 to 4.2; P = .76); and (3) cannabis use was not associated with a collapsed composite of pulmonary complications, with estimated odds ratio of 0.90 (95% CI, 0.71-1.13; P = .34). CONCLUSIONS: Adult cannabis users undergoing surgeries were found to have significantly higher postoperative opioid consumption and pain scores than nonusers. Cannabis use did not have a clinically meaningful association with hypoxia or composite pulmonary complications.
引用
- Ekrami E, Sari S, Kopac O, et al. Association Between Cannabis Use and Opioid Consumption, Pain, and Respiratory Complications After Surgery: A Retrospective Cohort Analysis. Anesth Analg. 2024. PMID: 38190341. doi:10.1213/ANE.0000000000006785
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。